KALV Competitors & Alternatives
Compare Kalvista Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
KALV
Main Stock$27.00
Tradestie Score
57
Market Cap
$608.81M
Revenue Growth
0.3%
Analyst Upside
+5.9%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.16
|
$1.55B | 13.5 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.19
|
$1.55B | - | 67 | Compare |
|
NVAX
Novavax Inc
|
$9.00
|
$1.54B | - | 54 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.88
|
$1.50B | 8.1 | 65 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$45.61
|
$1.50B | - | 57 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$16.37
|
$1.49B | - | 62 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$28.18
|
$1.43B | - | 55 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.91
|
$1.42B | - | 67 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.61
|
$1.35B | - | 61 | Compare |
|
MPLT
MPLT
|
$28.64
|
$1.34B | - | 54 | Compare |
More KALV Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry